Citation Impact
Citing Papers
Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program
2007 StandoutNobel
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Hepatitis C virus drug resistance–associated substitutions: State of the art summary
2015
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
High Affinity Peptide Inhibitors of the Hepatitis C Virus NS3-4A Protease Refractory to Common Resistant Mutants
2012
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Viral RNA Induces Type I Interferon-Dependent Cytokine Release and Cell Death in Mesangial Cells via Melanoma-Differentiation-Associated Gene-5
2009 StandoutNobel
Efficient T Cell Activation via a Toll-Interleukin 1 Receptor-Independent Pathway
2006 StandoutNobel
Liver fibrosis
2005 Standout
Sampling Variability of Liver Fibrosis in Chronic Hepatitis C
2003 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Viral genome imaging of hepatitis C virus to probe heterogeneous viral infection and responses to antiviral therapies
2016 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
Multi-input chemical control of protein dimerization for programming graded cellular responses
2019 StandoutNobel
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C
2005 Standout
Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B
2016
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs
2017
Cancer immunotherapy via dendritic cells
2012 Standout
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Critical comments on the WHO-UNEP State of the Science of Endocrine Disrupting Chemicals – 2012
2014
Resistance to nucleotide analogue inhibitors of hepatitis C virus NS5B: mechanisms and clinical relevance
2014
Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
2011
Discovery and development of telaprevir: an NS3-4A protease inhibitor for treating genotype 1 chronic hepatitis C virus
2011
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Innate immune recognition of viral infection
2006 Standout
Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment
2011
FIB-4
2007 Standout
tBuLi‐Mediated One‐Pot Direct Highly Selective Cross‐Coupling of Two Distinct Aryl Bromides
2015 StandoutNobel
Regulation of type I interferon responses
2013 Standout
The utility of radiological imaging in nonalcoholic fatty liver disease
2002 Standout
A computational approach for predicting off-target toxicity of antiviral ribonucleoside analogues to mitochondrial RNA polymerase
2018 StandoutNobel
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
2006 Standout
The role of liver biopsy in chronic hepatitis C
2002
Taming a beast: lessons from the domestication of hepatitis C virus
2019 StandoutNobel
Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA
2016 StandoutNobel
Genetic predisposition to autoimmunity – What have we learned?
2011
Current race in the development of DAAs (direct-acting antivirals) against HCV
2014
Nickel‐Catalyzed Cross‐Coupling of Organolithium Reagents with (Hetero)Aryl Electrophiles
2015 StandoutNobel
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
3d Transition Metals for C–H Activation
2018 Standout
Evaluation of Liver Fibrosis: A Concise Review
2004
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Polymorphisms in melanoma differentiation‐associated gene 5 link protein function to clearance of hepatitis C virus
2014 StandoutNobel
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Lipid Nanoparticles Delivering Constitutively Active STING mRNA to Stimulate Antitumor Immunity
2022 StandoutNobel
B7x in the Periphery Abrogates Pancreas-Specific Damage Mediated by Self-reactive CD8 T Cells
2012 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
The role of liver biopsy in chronic hepatitis C
2002
Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS 5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection
2014
Identification of AP80978, a Novel Small-Molecule Inhibitor of Hepatitis C Virus Replication That Targets NS4B
2014 StandoutNobel
Update of the Belgian Association for the Study of the Liver guidelines for the treatment of chronic hepatitis C genotype 1 with protease inhibitors.
2012
Fast Hepatitis C Virus RNA Elimination and NS5A Redistribution by NS5A Inhibitors Studied by a Multiplex Assay Approach
2015 StandoutNobel
Role of liver biopsy in management of chronic hepatitis C: A systematic review
2002
Validation of the FibroTest Biochemical Markers Score in Assessing Liver Fibrosis in Hepatitis C Patients
2003
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
2011
Localized Oncolytic Virotherapy Overcomes Systemic Tumor Resistance to Immune Checkpoint Blockade Immunotherapy
2014 StandoutNobel
Analysis of Ribonucleotide 5′-Triphosphate Analogs as Potential Inhibitors of Zika Virus RNA-Dependent RNA Polymerase by Using Nonradioactive Polymerase Assays
2016
RIG-I-Mediated Antiviral Responses to Single-Stranded RNA Bearing 5'-Phosphates
2006 StandoutScience
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Applications of Fluorine in Medicinal Chemistry
2015 Standout
CF2H, a Hydrogen Bond Donor
2017 Standout
Barrier-Independent, Fitness-Associated Differences in Sofosbuvir Efficacy against Hepatitis C Virus
2016 StandoutNobel
Works of Ivan Gentile being referenced
Myasthenia Gravis During Low-Dose IFN- α Therapy for Chronic Hepatitis C
2001
Multiple Sclerosis and Hepatitis C Virus Infection Are Associated with Single Nucleotide Polymorphisms in Interferon Pathway Genes
2008
A Novel Promising Therapeutic Option Against Hepatitis C Virus: An Oral Nucleotide NS5B Polymerase Inhibitor Sofosbuvir
2013
Etiopathogenesis of autism spectrum disorders: Fitting the pieces of the puzzle together
2013
Clinical and virological characteristics associated with severe acute hepatitis B
2014
Telaprevir: A Promising Protease Inhibitor for the Treatment of Hepatitis C Virus Infection
2009
The efficacy and safety of telaprevir – a new protease inhibitor against hepatitis C virus
2009
Treating Chronic Hepatitis B: Today and Tomorrow
2006
GS-9669: a novel non-nucleoside inhibitor of viral polymerase for the treatment of hepatitis C virus infection
2014
Daclatasvir: The First of a New Class of Drugs Targeted Against Hepatitis C Virus NS5A
2014
Investigational nucleoside and nucleotide polymerase inhibitors and their use in treating hepatitis C virus
2014
Multivariate Discriminant Function Based on Six Biochemical Markers in Blood Can Predict the Cirrhotic Evolution of Chronic Hepatitis
2001
Discontinued drugs in 2012 – 2013: hepatitis C virus infection
2014
NS5B polymerase inhibitors in phase II clinical trials for HCV infection
2017